OSG · Octave Specialty Group Inc

Track OSG — free

$4.90 +0.19 (+4.03%) At close · Aug 14

Market Cap

$220.75M

45.05M

Up next

Next earnings call

Nov 9, 2026 Est · unconfirmed · in 12 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 6, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 14.3 · calm Equity put/call 0.52

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −21%

below

Price vs 50-day avg −15%

below

RSI (14) 38

neutral

MACD trend Negative

52-week position 16%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −20%

trailing

6-month return −13%

trailing

YTD return −37%

this year

Relative strength −27%

vs S&P · 6-mo

Sentiment

smart money

Bearish

Trend (MA cross) No cross

50d $6 › 200d $6 — 200d above 50d

Institutional flow Distributing

-5% holders QoQ · +37 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

3.21% of float · ▲ +1.6% MoM · 4.5 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

142 holders — mid 3-yr range

Squeeze score 49

elevated · 0–100

Fundamentals

Strong

Revenue growth +7%

Y/Y

EPS growth +50%

Y/Y

Buyback $8.4M

remaining

Balance sheet $88.0M

net debt

Quant / Vol

risk profile

Very High

Volatility 68%

annualized · 1-yr

Max drawdown −61%

past year

ATR 5.3%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Jun 30, 2026

for OSG

Adjusted EBITDA Non-GAAP $45M

for Everspan

Adjusted EBITDA Non-GAAP $6M

for 2026

Adjusted net income per share Non-GAAP $0.15 – $0.20

by 2028

Adjusted EBITDA Non-GAAP $80M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

3 · 4 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−21% Bearish

Price vs 50-day avg

−15% Bearish

RSI (14)

38 Neutral

MACD trend

Negative Bearish

52-week position

16% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $6 › 200d $6 — 200d above 50d

Institutional flow Distributing

-5% holders QoQ · +37 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

3.21% of float · ▲ +1.6% MoM · 4.5 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

142 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $4 Now $5 · 16% Range high $10

vs 200-day avg -21% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDA non-GAAP	48.32M	Six Months Ended June 30	—
Adjusted EBITDA Margin non-GAAP	11%	Three Months Ended June 30, 2026	—
Adjusted EBITDA margin to shareholders non-GAAP	25.7%	Six Months Ended June 30	—
Adjusted net income (loss) after NCI margin non-GAAP	-2.2%	Three Months Ended June 30, 2026	—
Combined Ratio	124.1%	Six Months Ended June 30	—
Gross premium written	198.42M	Six Months Ended June 30	—
Loss Ratio	79.1%	Six Months Ended June 30	—
Net premiums written	55.59M	Six Months Ended June 30	—

Organic Growth non-GAAP	42.9%	Six Months Ended June 30	—
Premiums placed	741.2M	Six Months Ended June 30	—

Pretax income margin to shareholders	7%	Six Months Ended June 30	—
Specialty P&C Insurance (Everspan) Net premiums written	$13.88M	FY2026 Q2	+171.2%

Everspan active programs loss ratio	57%	Q1 2026	—
Insurance Distribution Segment Adjusted EBITDA non-GAAP	33M	Q1 2026	—
Insurance Distribution Segment Adjusted EBITDA margin to shareholders non-GAAP	32%	Q1 2026	—
Insurance Distribution Segment Adjusted EBITDA to Shareholders non-GAAP	$25M	Q1 2026	—
Insurance Distribution Segment Organic revenue growth	42%	Q1 2026	—
Insurance Distribution Segment Pre-tax income margin to shareholders	16%	Q1 2026	—
Insurance Distribution Segment Premiums placed	426.83M	Q1 2026	—
Specialty P&C Insurance (Everspan) Adjusted EBITDA to Shareholders non-GAAP	$1.6M	Q1 2026	—
Specialty P&C Insurance (Everspan) Gross premiums written	$104M	Q1 2026	—
Total P&C premium production	$531M	Q1 2026	—

Adjusted EBITDA to Shareholders non-GAAP	$7M	Q4 2025	—
Commission Income	$37M	Q4 2025	—
EBITDA to shareholders non-GAAP	6.91M	Q4 2025	—
Gross premiums written	$80M	Q4 2025	—
Organic revenue growth	8.1%	Q4 2025	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance - Specialty — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
OSG Octave Specialty Group Inc this stock	$220.75M	-37.0%	+6.5%	—	3.2%
FNF Fidelity National Financial, Inc.	$13.27B	-9.4%	+5.6%	—	3.4%
RYAN Ryan Specialty Holdings, Inc.	$10.70B	-19.0%	+21.3%	—	5.2%
FAF First American Financial Corp	$7.54B	+20.2%	+21.6%	10.2	5.8%
AXS Axis Capital Holdings Ltd	$7.46B	-5.5%	+10.2%	7.6	2.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

142

% held: 69.0%
Net QoQ: -2.4M sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

146

View

Short & Settlement

Short Interest Rising

Shares short

1.4M

Days to cover: 4.5d
Change: +23.4K sh

View

Short Volume

Short vol %

36%

As of: Aug 14, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $159
As of: Jul 8, 2026

View

Off-Exchange

Off-exchange %

40.0%

Week of: Jul 6, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$251.2M

Net income (FY): $-259.1M
EPS diluted: $-5.93

View

Buybacks

Authorized

$50.0M

Remaining: $8.4M

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 6, 2026
This year: 11

View

Proposed Sales

Value

$1.4M

Shares: 105.6K
Filed: Jun 26, 2023

View

Earnings & Events

Earnings Calls Upcoming

Next call

Sep 9, 2026

Last call: Aug 7, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
OSG	-0.6%	-19.8%	-13.1%	-9.3%	-37.0%
SPY	+0.4%	+4.5%	+13.8%	+3.9%	+13.9%
vs SPY	-1.0%	-24.3%	-26.9%	-13.2%	-50.9%

Capital returns

Buyback program · as of Jun 30, 2026

Authorized

$50.00M

Spent (derived)

$41.55M

Remaining

$8.45M

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 874501 CUSIP 023139884 13F (30d) 136 filings 135 filers Visit website Investor relations

OSG · Octave Specialty Group Inc

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns